Michael Donegan
2017
In 2017, Michael Donegan earned a total compensation of $531.5K as Vice President - Finance at TherapeuticsMD, a 42% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $68,875 |
|---|---|
| Option Awards | $157,898 |
| Salary | $290,000 |
| Other | $14,718 |
| Total | $531,491 |
Donegan received $290K in salary, accounting for 55% of the total pay in 2017.
Donegan also received $68.9K in non-equity incentive plan, $157.9K in option awards and $14.7K in other compensation.
Rankings
In 2017, Michael Donegan's compensation ranked 11,639th out of 14,666 executives tracked by ExecPay. In other words, Donegan earned more than 20.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,639 out of 14,666 | 21st |
Division Manufacturing | 4,570 out of 5,772 | 21st |
Major group Chemicals And Allied Products | 1,672 out of 2,075 | 19th |
Industry group Drugs | 1,383 out of 1,731 | 20th |
Industry Pharmaceutical Preparations | 1,080 out of 1,333 | 19th |
Source: SEC filing on April 27, 2018.
Donegan's colleagues
We found four more compensation records of executives who worked with Michael Donegan at TherapeuticsMD in 2017.